The Atlas Genetics io® system is a pioneering rapid diagnostic platform designed to detect the presence of infectious diseases such as Chlamydia and MRSA, where a quick, actionable test result provided on-demand can significantly improve patient outcomes.
Designed to meet CLIA Waiver, the platform comprises of a small, low cost, easy-to-use instrument (the io® Reader) and a test-specific disposable cartridge (the io® Cartridge) specifically designed for use in decentralised laboratories, point-of-care and other near-patient settings, providing a laboratory accurate test result in around 30 minutes.
A test and treat solution for STIs and HAIs
Healthcare professionals are under increasing financial pressures and are constantly striving to improve efficiency whilst maintaining a patient-centred approach to care. Moving patient testing away from centralised laboratories and into decentralised laboratories, point of care and other near-patient setting provides clinicians with actionable test results whilst the patient is still present. This enables a ‘test and treat’ solution, avoiding delays in treatment and the need for unnecessary follow-up appointments.
Using the io® System in a point of care setting
The io® system is a fully automated solution, requiring minimal hands-on time. Following the addition of an unprocessed patient specimen on to the io® Cartridge, the Cartridge is then inserted in to the io® Reader.
The user follows a few simple on-screen prompts to start the test, which is then performed under complete instrument control with no further user intervention necessary. Results are delivered without the need for any user interpretation.
To see a video of the io® system in action, click here. WATCH VIDEO
The system provides fully customisable user control settings, end-to-end specimen tracking, hospital/laboratory information system connectivity and an on-board Internal Process Control (IPC) which runs automatically to verify every test result.